Grant: Research Tools and Instruments - Category 1 (<$150,000)
McGill University
$78,654.00
Ultracentrifugation for the biochemical characterization of biomarkers involved in neurobiological functions
EF 2012-13
Résumé
Quantitative evaluation of synaptic and signaling proteins in various neuronal compartments forms an essential part of the research programs of the seven applicants. Western blotting (WB) is an indispensable technique for this purpose and is used routinely by us and other investigators at the Douglas Institute as well. However, in order to clearly pinpoint the functional significance of specific proteins involved in synaptic signalling, it is essential to determine their precise subcellular localization. Differential centrifugation to separate the subcellular organelle fractions of cell preparations is currently impossible due to the low speed of all existing centrifuges (<40,000g) at the Douglas Institute. The absence of an ultracentrifuge imposes a significant challenge to our research progress. Here we are proposing to apply for this essential piece of equipment: Beckman Optima MAX-XP Tabletop Ultracentrifuge for the research programs of seven investigators, to address important research questions in neurodevelopment, neuroimmunology, neuroendocrinology, and neurobiology of neurological and psychiatric disorders such as chronic pain, Alzheimer's disease, major depression and schizophrenia. The ultracentrifuge will allow us to obtain fractions of subcellular organelles and to examine the interested proteins in each fraction, thus leading to insights into the underlying mechanisms. The requested equipment is an invaluable tool for the accomplishment of the research programs of the seven applicants and will have a significant impact on research progress at the Douglas Institute. Ultracentrifuge is an essential tool for any cutting-edge molecular neuroscience research environment and will strengthen the competitiveness of Douglas researchers nationally and internationally.
Programme
Research Tools and Instruments - Category 1 (<$150,000)
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
439704-2013
Name nom
Ma, Weiya
Department département
Psychiatry
Organization id
61
Institution établissement
McGill University
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2012
Competition year année de concours
2013
Award amount
78654
Program id
EQPEQ
Program name en
Research Tools and Instruments - Category 1 (<$150,000)
Program name fr
Outils et instruments de recherche - catégorie 1 (<150 000$)
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
6400
Research subject group en
Life sciences research related to human health and disease
Research subject group fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Research subject en
Life sciences research related to human health and disease
Research subject fr
Sciences de la vie liées à la santé publique et aux maladies humaines
Partie
1
Nb partie
1
Application title
Ultracentrifugation for the biochemical characterization of biomarkers involved in neurobiological functions
Keyword
NSERC
Application summary
Quantitative evaluation of synaptic and signaling proteins in various neuronal compartments forms an essential part of the research programs of the seven applicants. Western blotting (WB) is an indispensable technique for this purpose and is used routinely by us and other investigators at the Douglas Institute as well. However, in order to clearly pinpoint the functional significance of specific proteins involved in synaptic signalling, it is essential to determine their precise subcellular localization. Differential centrifugation to separate the subcellular organelle fractions of cell preparations is currently impossible due to the low speed of all existing centrifuges (<40,000g) at the Douglas Institute. The absence of an ultracentrifuge imposes a significant challenge to our research progress. Here we are proposing to apply for this essential piece of equipment: Beckman Optima MAX-XP Tabletop Ultracentrifuge for the research programs of seven investigators, to address important research questions in neurodevelopment, neuroimmunology, neuroendocrinology, and neurobiology of neurological and psychiatric disorders such as chronic pain, Alzheimer's disease, major depression and schizophrenia. The ultracentrifuge will allow us to obtain fractions of subcellular organelles and to examine the interested proteins in each fraction, thus leading to insights into the underlying mechanisms. The requested equipment is an invaluable tool for the accomplishment of the research programs of the seven applicants and will have a significant impact on research progress at the Douglas Institute. Ultracentrifuge is an essential tool for any cutting-edge molecular neuroscience research environment and will strengthen the competitiveness of Douglas researchers nationally and internationally.